Direct laboratory pipelines accelerating functional supplement pipelines from natural raw screening to clinical dossiers.
Navigating the shift toward validated clinical efficacy, strict clean-label compliance, and sustainable active extraction.
Global brands are departing from generic herb powders. Today's commercial success depends on potency-standardized extracts backed by cellular mechanisms, pharmacokinetics, and certified human trial endpoints.
Regulatory frameworks such as US FDA 21 CFR Part 111, EU Novel Food authorizations, and TGA requirements necessitate absolute molecular traceability and verifiable freedom from micro-contaminants.
Modern consumers demand advanced delivery matrices: liposomal protection, sustained-release micro-beads, effervescent suspensions, and bioavailability-enhanced plant polyphenols.
Decades of specialized phytochemical engineering supported by multidisciplinary Chinese research faculties.
Combining upstream biodiversity clusters with high-throughput downstream pilot and industrial synthesis facilities.
China holds over 11,000 medicinal plant species. Our direct geographic access to authentic cultivation zones (GAP certified) cuts intermediary markups and prevents batch adulteration.
Proprietary analytical suites and partner GMP workshops allow rapid transition from microgram in vitro screening to multi-ton spray drying, supercritical CO₂ extraction, and resin chromatography.
Centralized engineering infrastructure, integrated energy optimization, and dense chemical equipment ecosystems deliver 35% to 50% operational cost efficiencies over Western contract facilities.
Customizing phytochemical formulations to match regional consumer demands and regulatory ceilings.
Formulations targeting insulin sensitivity using standardized berberine salts, mulberry leaf DNJ, and cinnamon polyphenols designed for instant release capsules and drink sachets.
Synergistic adaptogenic matrices combining standardized Withanolides, Rhodiola Salidrosides, and Jujube seed saponins, optimized for enteric softgels with enhanced blood-brain barrier transport.
Micro-encapsulated polyphenol blends including Resveratrol, Astragaloside IV, and Epimedium Icariin ensuring high bioavailability without mucosal irritation or degradation during storage.
Purified fungal and botanical polysaccharide complexes (Ganoderma lucidum, Astragalus membranaceus) verified by gel permeation chromatography (GPC) molecular weight distribution profiling.
As botanical science transitions to computational biology, MedGence deploys high-resolution mass spectrometry and in silico receptor binding models to revolutionize formulation stability.
Eliminating regulatory cross-border risks through strict legal safeguards and documentation dossiers.
Every research assay, formula recipe, and process parameter operates under ironclad bilateral Non-Disclosure Agreements (NDAs). Formula intellectual property belongs entirely to the commissioning buyer.
Comprehensive analytical certificates verifying conformity with USP, EP, BP, and ChP criteria: residual solvents, heavy metals (ICP-MS), pesticide screening, and microbial thresholds.
Supporting regulatory filings with stability testing data (ICH zones), analytical method validations, pre-clinical safety reports, and Phase I–IV human trial documentation for clinical supplement claims.
Clear, technical clarity for brand owners, product managers, and compliance auditors.
Unlike trading brokers who merely resell commercial bulk extracts, our CRO/CDMO architecture integrates primary laboratory screening, chromatography fingerprint establishment, stability optimization, and preclinical toxicological trials to build proprietary, high-margin finished formulas.
Yes. We conduct both in vitro cellular assays and formal human clinical trials (small-scale pilot groups or Phase I to IV configurations) to provide statistical validation suitable for supporting regulatory health claims in demanding markets.
Our analytical laboratories employ High-Performance Thin-Layer Chromatography (HPTLC), High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), and Mass Spectrometry (LC-MS/GC-MS) to generate reproducible chemical fingerprints.
Through systematic seasonal and geographic potency evaluation studies, we map active ingredient fluctuations across regions. We then select and lock in specific harvest cycles and origin criteria into standard operating procedures to guarantee uniform potency.
All contracted R&D activities are strictly governed by entrusted research contracts with non-disclosure clauses. Full data packages, experimental records, pilot synthesis logs, and patentable assets are delivered exclusively to the client.
Our facilities integrate in-house pilot laboratories directly with large-scale collaborative GMP workshops. Study results and process parameters scale without knowledge loss, from initial gram batches to commercial tonnage.
Access our validated methodology suites to fast-track your next commercial supplement pipeline.
Collaborate with MedGence (Yineng Pharma) scientists to architect a defensible, standardized nutraceutical formulation tailored to your regional market specifications.
